Short Interest in XOMA Co. (NASDAQ:XOMAP) Declines By 92.2%

XOMA Co. (NASDAQ:XOMAP) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totaling 122 shares, a drop of 92.2% from the April 15th total of 1,568 shares. Based on an average daily volume of 7,126 shares, the days-to-cover ratio is presently 0.0 days.

XOMA Trading Up 0.4%

NASDAQ:XOMAP traded up $0.10 during mid-day trading on Wednesday, hitting $25.37. The company had a trading volume of 2,079 shares, compared to its average volume of 2,150. The business has a fifty day simple moving average of $25.95 and a 200-day simple moving average of $26.28. XOMA has a 1 year low of $25.14 and a 1 year high of $30.00.

XOMA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Thursday, April 2nd were paid a dividend of $0.5391 per share. The ex-dividend date was Thursday, April 2nd. This represents a $2.16 annualized dividend and a dividend yield of 8.5%.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.